Pharmaceutical Raw Materials Sex Enhancement Series Flibanserin for Muscle Gain 167933-07-5
Abstract
CAS:167933-07-5
MF:C20H21F3N4O
MW:390.4
EINECS:1806241-263-5
storage temp. 2-8°C
solubility DMSO: soluble10mg/mL, clear
color white to beige
Hazard statements H301-H315-H319-H335
Precautionary statements P261-P301+P310-P305+P351+P338
Hazard Codes T
Risk Statements 25-36/37/38
Safety Statements 26-45
Description
Flibanserin is used for hypoactive sexual desire disorder among women. Those receiving flibanserin report a 0.5 increase compared to placebo in the number of times they had “satisfying sexual events”.In those on flibanserin it rose from 2.8 to 4.5 times a month while women receiving placebo reported also an increase of “satisfying sexual events” from 2.7 to 3.7 times a month.The onset of the flibanserin effect was seen from the first timepoint measured after 4 weeks of treatment and maintained throughout the treatment period.
The effectiveness of flibanserin was evaluated in three phase 3 clinical trials. Each of the three trials had two co-primary endpoints, one for satisfying sexual events (SSEs) and the other for sexual desire. Each of the 3 trials also had a secondary endpoint that measured distress related to sexual desire.
Application
Flibanserin is used for hypoactive sexual desire disorder among women. Those receiving flibanserin report a 0.5 increase compared to placebo in the number of times they had “satisfying sexual events”. In those on flibanserin it rose from 2.8 to 4.5 times a month while women receiving placebo reported also an increase of “satisfying sexual events” from 2.7 to 3.7 times a month.The onset of the flibanserin effect was seen from the first timepoint measured after 4 weeks of treatment and maintained throughout the treatment period.
COA
| Testing Items |
Specifications |
Results |
| Characteristics |
An off-white to white powder |
Complied |
| Identification |
Meet the requirements |
Positive |
| Loss on Drying |
≤0.50% |
0.13% |
| Heavy Metals |
≤20PPM |
<20PPM |
| Purity (by HPLC) |
≥99.0% |
99.2% |
| Conclusion: |
The commodity is complied with the standard of the factory |
1. Hot sales
| Testosterone Acetate |
Trenbolone Acetate |
T-A001 MGF 2mg |
| Testosterone Cypionate |
Trenbolone Enanthate |
T-A002 PEG MGF 2mg |
| Testosterone Decanoate |
Boldenone Acetate |
T-A003 CJC-1295 with DAC 2mg |
| Testosterone Enanthate |
Boldenone undecylenate |
T-A004 CJC-1295withoutDAC 2mg |
| Testosterone Isocaproate |
Boldenone Cypionate |
T-A005 PT-141 10mg |
| Testosterone Phenylpropionate |
Boldenone Propionate |
T-A006 MT-1 10mg |
| Testosterone Propionate |
Nandrolone Decanoate |
T-A007 MT-2 10mg |
| Testosterone Undecanoate |
Nandrolone phenylpropionate |
T-A008 GHRP-2 5mg |
| Mesterone |
Nandrolone undecylate |
T-A009 GHRP-6 5mg |
| Testosterone Sustanon 250 |
Nandrolone cypionate |
T-A009 GHRP-6 10mg |
| Clostebol Acetate |
Nandrolone propionate |
T-A010 Ipamorelin 2mg |
| Methylandrostanolone |
Methyltrienolone |
T-A011 Hexarelin 2mg |
| Methenolone Enanthate |
Drostanolone Propionate |
T-A012 Sermorelin 2mg |
| Methenolone Acetate |
Drostanolone Enanthate |
T-A013 Oxytocin 2mg |
| Anadrol |
Stanolone |
T-A014 TB500 2mg |
| Anavar |
Tadalafil |
T-A015 pentadecapeptide BPC 157 2mg |
| Winstrol |
Vardenafil |
T-A016 GH 176-191 2mg |
| Clomifene citrate |
Dianabol |
T-A017 Triptorelin 2mg |
| Toremifene citrate |
Tamoxifen Citrate |
T-A018 Tesamorelin 2mg |
| Finasteride |
hydrochloride |
T-A020 Gonadorelin 2mg |
| T-A022 Selank 5mg |
T-A021 DSIP 2mg |
T-A020 Gonadorelin 10mg |
Sales Manager